As of 2025-07-19, the Relative Valuation of Landos Biopharma Inc (LABP) is (132.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -679.6%.
The range of the Relative Valuation is (123.90) - (141.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 17.8x | 14.7x |
| Forward P/E multiples | 15.6x - 21.7x | 18.8x |
| Fair Price | (123.90) - (141.17) | (132.89) |
| Upside | -640.3% - -715.7% | -679.6% |
| Date | P/E |